Results for Speaking Out
Managers get it. Do investors?
March 02, 2016 Why hasn’t the ethical investment movement had more impact, asks Mike Tuffrey. And now that professional investment managers increasingly understand the issues, will more investors follow? Read more >
The evolving relationship between sustainability and marketing
March 02, 2016 Emma Upton discusses the new hybrid marketing models that are taking sustainability messages direct to consumers. Read more >
How do you solve a problem like POPS?
March 02, 2016 Michael Hegarty looks at London's raging debate over privately-owned public space (POPS). What is the responsibility of companies to protect and preserve urban environments? Read more >
Environmental funding after COP21
February 05, 2016 The Paris Climate Summit has highlighted the role for private investment in climate finance. It is now up to funders – both corporate and non-corporate – to shape the path ahead, writes Eva Rehse. Read more >
Invest or give – what’s the difference?
February 05, 2016 Mike Tuffrey takes a trip down memory lane to ask whether loans or grants are the right approach to getting results for the community. Read more >
When is a lobbyist not a lobbyist? When they’re a customer.
February 05, 2016 A growing number of companies are recruiting their customers as freelance lobbyists. But companies should be wary of trying to control public debate, writes Charlie Ashford. Read more >
Delivering on the SDGs will require a system reboot
February 02, 2016 The new Sustainable Development Goals are a valuable new framework for companies to develop their business models, writes Jules Peck. But truly progressive businesses also need to engage with civil society to evolve the goals. Read more >
The why of sustainability reporting
December 16, 2015 CSR is no longer a tagline: Garrett Weiner gives a perspective on sustainability reporting trends from Singapore. Read more >
Climate change: a global healthcare challenge
December 16, 2015 The links between climate change and health must be addressed, says GSK's Matt Wilson. Will the Paris Agreement be a turning point? Read more >